What is the typical adult dose for an intravenous omeprazole infusion (drip)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typical Dose for Omeprazole Drip

For adult patients with upper gastrointestinal bleeding, administer omeprazole as an 80 mg intravenous bolus followed by a continuous infusion of 8 mg/hour for 72 hours after endoscopic hemostasis. 1, 2, 3

Standard Dosing Protocol

Initial Bolus

  • Administer 80 mg IV omeprazole as a bolus injection immediately upon presentation, even before endoscopy is performed 1, 2, 3
  • This initial bolus should be given as soon as upper GI bleeding is suspected 3

Continuous Infusion

  • Following the bolus, start a continuous infusion at 8 mg/hour 1, 2, 3
  • Continue this infusion for exactly 72 hours after successful endoscopic hemostasis 1, 2, 3
  • This high-dose regimen maintains gastric pH above 6, which is necessary for platelet aggregation and clot stability 1

Preparation

  • Mix 240 mg omeprazole in 240 mL of normal saline or 5% dextrose to create a 1 mg/mL solution 1
  • Alternatively, use 160 mg in 200 mL (0.8 mg/mL concentration) with an infusion rate of 10 mL/hour to achieve 8 mg/hour 1

Evidence Supporting This Regimen

This high-dose continuous infusion protocol has demonstrated:

  • Mortality reduction (OR 0.56,95% CI 0.34-0.94) compared to no PPI or H2-receptor antagonists 1, 3
  • Reduced rebleeding rates (OR 0.43,95% CI 0.29-0.63) 1, 3
  • Decreased need for surgical intervention 1

The rationale is that blood clot stability requires a gastric pH above 6, and clot lysis occurs when pH drops below 6 1

Post-Infusion Management

Transition to Oral Therapy

  • After completing the 72-hour infusion, transition to oral PPI 40 mg twice daily 1, 2, 3
  • Continue oral PPI 40 mg once daily after day 14 1, 2
  • Total duration should be 6-8 weeks minimum to allow complete mucosal healing 1, 2, 3

Patient Selection

This high-dose regimen is specifically indicated for patients with high-risk endoscopic stigmata, including:

  • Active arterial bleeding 3
  • Visible vessel 3
  • Adherent clot 3

Patients with low-risk stigmata do not require this intensive regimen 3

Critical Pitfalls to Avoid

  • Never rely solely on PPI therapy without endoscopic intervention in active bleeding—PPIs are adjunctive therapy to endoscopic hemostasis, not a replacement 1, 2, 3
  • Do not use lower doses in high-risk patients, as only the high-dose continuous infusion has demonstrated mortality benefit 1, 3
  • Do not discontinue therapy before 6-8 weeks, as premature discontinuation prevents adequate mucosal healing 1, 2, 3
  • Administer the infusion slowly to avoid thrombophlebitis at the infusion site, which can occur with too-rapid administration through peripheral veins 1

Alternative Dosing (Less Optimal)

While 40 mg IV bolus twice daily has been studied 4, 5, research shows that a single 40 mg dose is only as effective as the 80 mg bolus plus 8 mg/hour infusion for the first 12 hours 5. To maintain intragastric pH above 6 for the full 24 hours in all patients, the 80 mg bolus followed by 8 mg/hour infusion is superior 5.

References

Guideline

Management of Upper Gastrointestinal Bleeding with Omeprazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Upper Gastrointestinal Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pantoprazole Infusion Guidelines for Upper GI Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.